Key facts
- Sayvant’s last known valuation is $15.0M (Mar 2025).
- It has raised $3.0M; the latest was Seed Round ($3.0M) in Mar 2025.
- Notable investors include Baleon Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sayvant
- ·The full record, as it builds
Funding rounds
No funding rounds for Sayvant are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sayvant
Developer of a healthcare platform designed to streamline medical charting in acute care settings like emergency departments and urgent care facilities. The company uses voice dictation and AI to instantly generate clinically validated, detailed notes for patient encounters by providing a defensible chart that is compliant with regulatory and billing standards, enabling healthcare professionals to reduce the charting time spent on documentation and ensure accurate billing and quality measure capture.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 13
- Website
- sayvant.com/
- Ownership
- Privately Held (backing)
Sayvant doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sayvant shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sayvant in its N-PORT filings yet. We sweep new filings monthly.